Quaternized Poly(vinylpyrrolidone-co-4-vinylpyridine) Copolymers for siRNA Delivery

Abstract

Polymers offer a promising alternative to established lipid nanoparticles for therapeutic RNA delivery. Here, we introduce alkyl-chain-quaternized poly(vinylpyrrolidone-co-4-vinylpyridine) copolymers (PVP-co-PVPy) for siRNA delivery, marking their first reported use for this purpose to the best of our knowledge.

These polymers are easily synthesized via a two-step synthesis, starting with a free-radical polymerization of two inexpensive monomers, followed by quaternization with an iodoalkane. Formulation involves simple batch mixing in PBS, reproducibly yielding small spherical particles. The functional performance of the polymers as siRNA carriers, assessed by in vitro gene silencing of the enhanced green fluorescent protein (eGFP) reporter gene, as well as their cytotoxicity, both depend on the ratio of the two monomers and the alkyl chain length.

The best-performing polymers in this study both feature a decyl chain and monomer ratios of PVP/PVPy between 65/35 and 70/30, achieving eGFP knockdown of 70–80% while maintaining around 70–80% cell viability.

Download the supporting information as PDF here Quaternized Poly(vinylpyrrolidone-co-4-vinylpyridine) Copolymers for siRNA Delivery

or continue reading here

Valentin H. K. Fell, Carolina S. Fuchs, Sahana Sheshachala, Leon Reger, Sebastian Sturm, David C. Jürgens, Knut Müller-Caspary, Nathan B. P. Adams, Olivia M. Merkel; Quaternized Poly(vinylpyrrolidone-co-4-vinylpyridine) Copolymers for siRNA Delivery. ACS Appl. Polym. Mater. 2026; https://doi.org/10.1021/acsapm.6c02385

Read more on the:

Breast Cancer Awareness Month 2026